John J. Sperzel III - 20 Feb 2024 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chairman, President and Chief Executive Officer, Director
Signature
/s/ John Sprague, Attorney-in-fact
Issuer symbol
TTOO
Transactions as of
20 Feb 2024
Net transactions value
$0
Form type
4
Filing time
20 Feb 2024, 16:00:17 UTC
Previous filing
09 Mar 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +160 +92% 333 20 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -160 -50% $0.000000 160 20 Feb 2024 Common Stock 160 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 On February 20, 2022 the reporting person was granted 480 RSU's that vest in three equal annual installments commencing on February 20, 2023

Remarks:

Chairman, President and Chief Executive Officer